North Alabama
Counties: Lauderdale, Limestone, Lawrence, Franklin, Marion, Winston, Morgan, Marshall, DeKalb, Blount, Cherokee, Lamar and Fayette.
OTP city search starting points: Sheffield, Huntsville, Cullman, Gadsden, Stevenson or Jasper.
Find Alabama methadone clinics, compare medication choices and learn how Medicaid and treatment referrals work. The Alabama Department of Mental Health (ADMH) reports 21 certified opioid treatment programs in 16 counties; the September 2026 CMS directory identifies 18 Medicare-enrolled locations.
What this means for you: Alabama offers several medication paths, but costs and travel may vary by county. The 18 CMS-listed sites are a directory of Medicare-enrolled programs, not a count of every certified program.
Need help exploring Alabama treatment options?
Compare medication care, provider questions and payment pathways. Treatment availability depends on the clinic.
Call 1-(347) 591-7540For overdose or immediate danger, call 911. For crisis support call or text 988. SAMHSA National Helpline: 1-800-662-4357.
MATClinicGuide.com is a treatment-navigation resource, not a treatment provider. Calls may be routed to participating treatment providers or navigation partners.
Alabama's September 2026 CMS enrollment directory lists 18 Medicare-enrolled opioid treatment program (OTP) locations in 16 cities. Birmingham and Huntsville each have two, while the other listed cities each have one. Choose a city below to see contact information and driving directions.
The following entries reflect Medicare-enrolled OTP locations in the CMS September 8, 2026 file. ADMH's larger state-certified program count includes additional programs that are not represented in this directory.
750 Highway 31 S, Alabaster, AL 35007-4627
5605 Clifford Cir, Birmingham, AL 35210-4453
2500 4Th Ave S, Birmingham, AL 35233
2100 Holiday Inn Dr, Clanton, AL 35046-6200
1912 Commerce Avenue Northwest, Cullman, AL 35055-6150
1121 Gardner St, Gadsden, AL 35901-3038
12271 Interchange Drive, Grand Bay, AL 36541
4040 Independence Dr NW, Huntsville, AL 35816-3012
2227 Drake Ave SW, Ste 19, Huntsville, AL 35805-5146
2195 N Airport Rd, Jasper, AL 35504-7057
808 Downtowner Loop W, Mobile, AL 36609-5519
6001 E Shirley Ln, Montgomery, AL 36117-1935
9283 W US 84, Newton, AL 36352-8207
118 E Choccolocco St, Oxford, AL 36203-1222
3430 N Jackson Hwy, Sheffield, AL 35660-3512
196 County Road 85, Stevenson, AL 35772-5522
1001 Mimosa Park Rd, Tuscaloosa, AL 35405-4843
Many Alabama patients receive buprenorphine through office-based addiction-medicine, primary-care or psychiatry practices instead of methadone OTPs. Search FindTreatment.gov by ZIP code and medication, or use the ADMH provider search to explore nearby substance use services.
ADMH reports certified adult substance use services, including outpatient and medication-assisted treatment, in 59 of Alabama's 67 counties. Ask a provider whether it offers buprenorphine, extended-release naltrexone, telehealth appointments or counseling.
Listings are based on public federal data dated September 8, 2026. Call to confirm intake, hours, insurance and available medications.
Medication assisted treatment in Alabama can involve methadone, buprenorphine or naltrexone, depending on clinical needs and care setting. These are evidence-based treatments for opioid use disorder; a clinician can help compare the benefits and limitations.
ADMH reports 21 certified methadone OTPs in 16 Alabama counties, and CMS lists 18 Medicare-enrolled locations. Programs are concentrated in cities such as Birmingham and Huntsville, with sites also listed in Mobile, Montgomery, Tuscaloosa, Newton and other communities. Methadone for opioid use disorder is dispensed through a certified OTP; patients may start with frequent in-person visits. Take-home arrangements depend on clinical assessment and applicable regulations.
Read about methadone treatment and how opioid treatment programs work.
Alabama residents may be able to obtain buprenorphine from qualified office-based clinicians, and some clinicians may offer telehealth visits. Suboxone is a buprenorphine/naloxone product; other buprenorphine formulations are available. Alabama Medicaid covers medically necessary buprenorphine treatment for eligible beneficiaries subject to the program's drug and service rules. The former federal X-waiver requirement ended in 2023, but clinicians still must meet applicable prescribing requirements.
Explore buprenorphine and Suboxone treatment or MAT versus MOUD terminology.
Monthly or other extended-duration injections may be useful for some adults receiving buprenorphine treatment, based on the product and prescribing clinician's assessment. Alabama Medicaid's MAT benefit includes FDA-approved forms of buprenorphine for eligible patients when medical-necessity requirements are met. Access to a specific injection depends on the prescribing practice, product rules and payment arrangements. Ask whether an Alabama provider administers the injection on site and what steps are needed before starting.
See the Sublocade guide and ask about other formulations such as Brixadi.
Extended-release naltrexone (Vivitrol) is another medication option for opioid use disorder, but it works differently from opioid agonist medicines. It generally requires an opioid-free period before the first dose, which a medical professional should supervise. Alabama Medicaid covers medically necessary naltrexone, with its plan amendment specifying up to one Vivitrol injection per month, subject to relevant policies. Ask an Alabama treatment provider whether naltrexone is appropriate and whether it offers administration.
Read more about Vivitrol and naltrexone treatment.
| Medication | Where available in Alabama | Visits at the start | Alabama Medicaid |
|---|---|---|---|
| Methadone | Certified OTPs | Often frequent in-person dosing | Covered when medically necessary |
| Buprenorphine / Suboxone | Office-based prescribers; some OTPs | Depends on clinical plan | Covered when medically necessary |
| Sublocade / Brixadi | Qualified administering providers | Injection schedule depends on product | FDA-approved buprenorphine forms covered, subject to rules |
| Naltrexone / Vivitrol | Prescribers and injection providers | Assessment, then injection schedule if appropriate | Covered when medically necessary |
The Alabama Department of Mental Health certifies opioid treatment programs, and OTPs also operate under federal SAMHSA and DEA requirements, including 42 CFR Part 8. For opioid use disorder, methadone is provided through OTP care rather than an ordinary take-home prescription from an office-based doctor.
At an Alabama OTP, a patient generally discusses their opioid use history, current medications, physical health, safety concerns and care goals with the intake team. The clinic determines eligibility, medical assessment steps and when treatment could begin. An OTP may also help explain insurance benefits and whether additional care such as counseling is available; counseling is not a universal prerequisite to starting medication.
Federal OTP regulations updated in 2024 allow greater clinical flexibility in decisions about take-home doses. Alabama-certified OTPs must also follow applicable state rules and their own clinical policies, so schedules differ by patient and program. If you travel or change towns, ask the OTP about guest dosing and transfer coordination well in advance.
Alabama Medicaid covers medically necessary methadone, buprenorphine and naltrexone for eligible beneficiaries under State Plan Amendment AL-25-0015, effective October 1, 2025 and approved by CMS on February 6, 2026. Methadone for opioid use disorder must be provided through an OTP. Covered MAT-related services include intake evaluation, medical assessment, treatment planning, counseling and peer support.
Alabama has not adopted ACA Medicaid expansion, according to KFF (October 2026). As a result, some low-income adults, including many adults without dependent children, may not meet eligibility rules. The Alabama Medicaid Agency provides eligibility and benefit information.
| Service | Alabama Medicaid covered? | Notes |
|---|---|---|
| Methadone for OUD | Yes | Through an OTP; medical necessity applies |
| Buprenorphine | Yes | FDA-approved forms; preferred drug and quantity policies |
| Naltrexone / Vivitrol | Yes | Vivitrol limit of one injection per month, subject to rules |
Alabama's Medicaid MAT amendment lists up to 365 units per year for oral methadone/buprenorphine administration and allows medical-necessity overrides of certain limits. Individual approvals and billing details are determined through Medicaid and treating providers.
Medicare Part B offers an OTP benefit for eligible people receiving covered opioid treatment services. Outpatient prescriptions for some buprenorphine or naltrexone products may involve Medicare Part D and the member's plan. The 18 Alabama sites shown above appear in CMS's Medicare-enrolled OTP provider file, but patients should check their own coverage and clinic billing.
Alabama private insurance benefits differ by plan, deductible, network and medication. Mental health parity protections do not mean every product or appointment is automatically covered. Ask the insurer and Alabama treatment clinic about authorization, pharmacy benefits, program fees and out-of-pocket costs.
ADMH-certified providers offer publicly funded substance use services in Alabama. ADMH says there are no admission fees for pregnant women or women with dependent children in its women's services. Other people should ask providers about publicly funded treatment eligibility, payment options and availability. See MAT cost and insurance, insurance coverage basics and how to verify insurance.
Need help checking Alabama treatment options?
Talk to our treatment-navigation line about options to explore and questions for providers.
Call 1-(347) 591-7540Telehealth Suboxone in Alabama may be possible through an eligible prescriber, but appointment format and prescribing depend on clinical and legal requirements. Federal DEA/HHS telemedicine flexibilities for controlled-medication prescribing remain in effect through December 31, 2026; Alabama rules and provider policies may impose additional requirements, and rules can change.
A clinician may use telehealth for an assessment or appropriate follow-up, but methadone for opioid use disorder must still be dispensed by an OTP under applicable rules. Patients may need in-person visits for examinations, injectable medicines or other services. See the telehealth MAT guide for questions to ask prospective providers.
Alabama recorded 1,211 drug overdose deaths in 2024, according to CDC NCHS data reported by USAFacts. Its 2024 age-adjusted rate for drug overdose deaths was 25.0 per 100,000, above the national rate of 23.1. The Alabama rate declined from 33.9 in 2023, but overdose prevention and treatment access remain important.
Age-adjusted drug overdose deaths per 100,000; CDC NCHS via KFF State Health Facts.
| Year | Alabama all-drug rate | Alabama opioid rate | U.S. all-drug rate |
|---|---|---|---|
| 2022 | 31.5 | 23.4 | 32.6 |
| 2023 | 33.9 | 25.7 | 31.3 |
| 2024 | 25.0 | 17.3 | 23.1 |
Alabama's opioid overdose death rate was 17.3 per 100,000 in 2024, compared with 16.0 nationally. Access to medication treatment and overdose reversal with naloxone can be parts of a practical prevention plan; these numbers do not describe any individual person's prognosis.
In the September 2026 CMS list, 53 Alabama counties have no Medicare-enrolled OTP; this does not mean they have no state-certified methadone program or other addiction treatment. The regions below give nearby OTP city search starting points, not proven closest routes; check travel options and the ADMH provider directory before making plans.
Counties: Lauderdale, Limestone, Lawrence, Franklin, Marion, Winston, Morgan, Marshall, DeKalb, Blount, Cherokee, Lamar and Fayette.
OTP city search starting points: Sheffield, Huntsville, Cullman, Gadsden, Stevenson or Jasper.
Counties: St. Clair, Talladega, Clay, Cleburne, Randolph, Coosa, Tallapoosa, Chambers, Lee, Russell, Elmore, Autauga, Macon and Bibb.
OTP city search starting points: Birmingham, Alabaster, Oxford, Clanton or Montgomery.
Counties: Pickens, Greene, Sumter, Hale, Perry, Marengo, Choctaw, Dallas, Wilcox, Lowndes and Bullock.
OTP city search starting points: Tuscaloosa, Montgomery or Mobile.
Counties: Baldwin, Washington, Clarke, Monroe, Conecuh, Escambia, Butler, Crenshaw, Covington, Pike, Barbour, Coffee, Geneva, Henry and Houston.
OTP city search starting points: Mobile, Grand Bay, Newton or Montgomery.
ADMH reports certified adult substance use treatment across 59 of Alabama's 67 counties, even though methadone OTP coverage is less widespread. Residents of Baldwin, Lee, Houston, Dallas and other counties without a CMS-enrolled OTP can also explore office-based buprenorphine or telehealth where clinically and legally appropriate.
RSA Union Building, 100 North Union Street
Montgomery, AL 36104
Check Alabama Medicaid eligibility, MOUD benefits and covered services.
Call or text 988 for a mental health crisis; call 911 for suspected overdose or immediate danger.
Alabama Act 2015-8 permits qualifying naloxone prescriptions and dispensing through standing orders, including to family, friends and others positioned to help a person at risk. The law also describes protections for people administering naloxone with reasonable care. Naloxone is also available over the counter nationally.
ADMH lists R.O.S.S. (Recovery Organization of Support Specialists) at 1-844-307-1760 as a 24/7 substance use support helpline. Other ADMH-listed resources include the Council on Substance Abuse at 1-877-HELP-4AL and People Engaged in Recovery at 1-888-421-7347.
Alabama's overdose Good Samaritan protection is limited. Under the conditions set out in Act 2015-8, a person seeking help for someone else's overdose may be protected from prosecution for certain misdemeanor controlled-substance offenses. The protection does not extend to felonies.
ADMH women's services prioritize admission for pregnant women and describe programs for pregnant and parenting women where children may stay with their mothers. ADMH reports no admission fees for pregnant women or women with dependent children in those services. Pregnant patients should discuss medication options with qualified obstetric and addiction-care clinicians, rather than stopping treatment abruptly.
Veterans in Alabama can ask their VA care team about substance use evaluation and medication for opioid use disorder, including referrals to appropriate VA or community care options. Eligibility, site services and appointment availability depend on the individual program. Veterans may also use the Alabama OTP directory and ADMH provider search to identify local care options.
ADMH reports certified adolescent substance use services for ages 13–18, including outpatient through residential levels of care. Medication choices for younger patients require careful clinical evaluation and age-appropriate services. A parent, caregiver or young person can use the ADMH provider search to identify programs serving adolescents and ask about confidentiality and consent rules.
For someone returning to an Alabama community after incarceration, continuity of existing medication treatment can be especially important. Before release, ask a discharge planner, case manager or outside provider about appointments, Medicaid eligibility and how to avoid a gap in medication. If a referral is not arranged, the ADMH directory and CMS-listed OTPs provide starting points.
People in Alabama counties without a Medicare-enrolled OTP may have longer journeys for methadone dosing. Office-based buprenorphine and allowable telehealth appointments may reduce some travel needs. ADMH reports broader adult substance use service availability in 59 counties, so a local assessment or referral service may exist even where no Medicare-enrolled methadone program is listed.
A useful Alabama MAT clinic should explain its medication options, intake process, costs and follow-up plan without promising a guaranteed outcome. Compare programs based on clinical needs, transportation, insurance and how well a provider answers your questions.
Ready to ask about Alabama treatment?
Talk to our treatment-navigation line about options to explore and questions for providers.
Call 1-(347) 591-7540The Alabama Department of Mental Health reported 21 certified opioid treatment programs across 16 counties in September 2026. The CMS Medicare enrollment file dated September 8, 2026, lists 18 locations across 16 cities and 14 counties. The directory above shows the 18 Medicare-enrolled locations; the ADMH provider search can help locate additional certified programs.
Yes. Alabama Medicaid covers medically necessary buprenorphine treatment for eligible beneficiaries, including FDA-approved forms, under State Plan Amendment AL-25-0015. Preferred drug lists, generic-first policies and quantity limits may affect individual prescriptions. Alabama has not expanded Medicaid under the Affordable Care Act, so not every low-income adult will qualify.
Yes. Alabama Medicaid includes medically necessary methadone treatment for opioid use disorder when it is furnished through an opioid treatment program. Alabama Medicaid’s 2025 state plan amendment describes covered services such as evaluations and treatment planning. Eligibility and billing rules still matter; ask the OTP how it handles Alabama Medicaid before an intake visit.
Some people may qualify for publicly funded substance use treatment through ADMH-certified providers. That does not mean every methadone clinic is free. ADMH states that pregnant women and women with dependent children have no admission fees in its women’s services. For other help with payment, contact ADMH or ask a provider about available funding.
Telehealth may be an option for buprenorphine care in Alabama, depending on the provider, the patient’s circumstances and applicable requirements. Federal DEA/HHS controlled-medication telemedicine flexibilities are in effect through December 31, 2026, while state and clinical rules may add conditions. Confirm the appointment format and prescribing process with the clinician.
The CMS September 2026 list contains two methadone OTP locations in Birmingham: Metro Treatment of Alabama LP at 5605 Clifford Circle and at 2500 4th Avenue South. A third CMS-listed location in Jefferson County is TTC, LLC in Bessemer. Open the Birmingham and Bessemer directory entries above for phone numbers and directions.
Office-based buprenorphine care may be available through primary care, psychiatric and addiction-medicine practices. Search FindTreatment.gov by ZIP code and treatment type, or use the ADMH provider search. Ask whether the clinician accepts your coverage and whether office visits or telehealth are offered. Methadone OTP listings should not be mistaken for a complete list of buprenorphine providers.
Naltrexone, including extended-release Vivitrol, is one of the medication options covered by Alabama Medicaid for beneficiaries who meet medical-necessity rules. Starting naltrexone generally requires an opioid-free period to avoid precipitated withdrawal. Ask a qualified clinician whether this option fits your health needs and where injections are offered.
A county may have no Medicare-enrolled OTP in the CMS September 2026 directory but still have other substance use treatment services. ADMH reports certified substance use services in 59 of Alabama’s 67 counties. Search the ADMH provider directory and FindTreatment.gov, and ask about office-based buprenorphine or a telehealth consultation.
Ask about a photo ID, insurance or Alabama Medicaid information, medication list, medical history and any prior treatment records. Clinics set their own intake steps and may ask about pregnancy, withdrawal symptoms and safety needs. If transportation or payment is a concern, mention it when scheduling so staff can explain the options available at that location.
The Alabama directory was compiled from the CMS Medicare Opioid Treatment Program Providers file dated September 8, 2026, with city and county groupings. Its 18 Medicare-enrolled locations are not a complete census of Alabama-certified OTPs; ADMH reports 21 certified locations in 16 counties. Clinical and insurance information should be confirmed with the individual provider.
MATClinicGuide.com is an educational and treatment-navigation resource, not a healthcare provider. It does not diagnose, prescribe, treat or own or operate the clinics listed here. Calling our telephone line connects you with MATClinicGuide's treatment-navigation line rather than the listed clinic; calls may be answered by or routed to participating treatment providers or navigation partners. Confirm each clinic's licensing, availability, services, prices and insurance terms directly. Information here is not a substitute for medical advice. For an overdose or other medical emergency call 911; for a mental health crisis, call or text 988.
Read our editorial policy, medical disclaimer and advertising and referral disclosure.
Explore the national state treatment hub for guides to finding medication treatment in other areas.
Coming soon: Mississippi, Tennessee, Georgia and Florida.